These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20503457)
1. Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma. Zhang KJ; Zhang BY; Zhang KP; Tang LM; Liu SS; Zhu DM; Zhang DL World J Gastroenterol; 2010 May; 16(20):2554-7. PubMed ID: 20503457 [TBL] [Abstract][Full Text] [Related]
2. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
3. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma. Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients. Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558 [TBL] [Abstract][Full Text] [Related]
5. The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value. Tian X; Wang Q; Li Y; Hu J; Wu L; Ding Q; Zhang C Pathol Oncol Res; 2015 Jan; 21(1):195-201. PubMed ID: 24985031 [TBL] [Abstract][Full Text] [Related]
6. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway. Zhao S; Wang J; Qin C J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma. Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of snail expression in hilar cholangiocarcinoma. Kong D; Liang J; Li R; Liu S; Wang J; Zhang K; Chen D Braz J Med Biol Res; 2012 Jul; 45(7):617-24. PubMed ID: 22570087 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of Sox2, CD44 and CD44v6 expression in intrahepatic cholangiocarcinoma. Gu MJ; Jang BI Pathol Oncol Res; 2014 Jul; 20(3):655-60. PubMed ID: 24482053 [TBL] [Abstract][Full Text] [Related]
11. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Su MC; Hsu C; Kao HL; Jeng YM Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases. Laohaviroj M; Chamgramol Y; Pairojkul C; Mulvenna J; Sripa B Asian Pac J Cancer Prev; 2016; 17(1):201-5. PubMed ID: 26838210 [TBL] [Abstract][Full Text] [Related]
13. The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma. Zhang KJ; Wang DS; Zhang SY; Jiao XL; Li CW; Wang XS; Yu QC; Cui HN J Exp Clin Cancer Res; 2010 Jul; 29(1):88. PubMed ID: 20594328 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859 [TBL] [Abstract][Full Text] [Related]
15. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma. Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma. Hirashita T; Iwashita Y; Ohta M; Komori Y; Eguchi H; Yada K; Kitano S J Gastrointest Surg; 2012 Apr; 16(4):842-8. PubMed ID: 22246855 [TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma. Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275 [TBL] [Abstract][Full Text] [Related]
18. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma. Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma. Yang XQ; Xu YF; Guo S; Liu Y; Ning SL; Lu XF; Yang H; Chen YX World J Gastroenterol; 2014 Apr; 20(14):4076-84. PubMed ID: 24744599 [TBL] [Abstract][Full Text] [Related]
20. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]